每经AI快讯，1月7日，华康洁净（301235）公告称，股东阳光（600673）人寿保险股份有限公司计划 减持不超过313.11万股，占剔除公司回购专用账户股份后总股本的3%。减持方式为集中竞价交易和大 宗交易，减持原因为经营发展需要，减持期间为公告披露之日起3个交易日后的3个月内(2026年1月13日 至2026年4月12日)。 ...

| 代码 | 简称 | 收盘价（元） | 涨跌幅（%） | 换手率（%） | 成交额（万元） | | --- | --- | --- | --- | --- | --- | | 920077 | 吉林碳谷 | 18.30 | 23.65 | 12.85 | 71043.36 | | 920091 | 大鹏工业 | 88.60 | 14.35 | 52.23 | 60446.37 | | 920576 | 天力复合 | 75.89 | -5.79 | 6.41 | 53098.84 | | 920116 | 星图测控 | 85.45 | -3.76 | 13.05 | 45644.09 | | 920274 | 宏裕包材 | 32.23 | -23.81 | 13.71 | 38841.34 | | 920640 | 富士达 | 38.72 | -1.22 | 5.14 | 35990.76 | | 920160 | 北矿检测 | 28.01 | -3.31 | 46.74 | 35393.08 | | 920185 | 贝特瑞 | 32.86 | -2.58 | 0.89 | 32583.58 | | 920 ...

证券时报·e公司记者注意到，近期以来，多家A股上市公司宣布提高独立董事的津贴水平。 12月22日晚间，三超新材披露，公司董事会审议通过议案，拟将独立董事津贴由5万元/年（税前）调整 为12万元/年（税前）。调整后的独立董事津贴标准自公司2026年第一次临时股东会审议通过之日起开 始执行。 对于"涨薪"行为，三超新材称是为更好地发挥独立董事参与决策、监督制衡与专业咨询作用，且参考了 所处地区经济发展水平及同行业上市公司独立董事津贴情况。 整体来看，上市公司给独立董事"涨薪"大多基于：建立科学合理的激励机制，调动独立董事履职积极 性，进一步促进独立董事的勤勉尽责，发挥独立董事的科学决策和监督作用等等。 有分析人士认为，近年来监管层对独立董事履职中存在的问题频频"亮剑"，责任的加大，倒逼独立董事 重视履职。在此情况下，如果没有相应的激励措施，可能会导致独立董事逐步丧失履职积极性。因此， 给独立董事"加薪"具有正向意义。 中国上市公司协会今年3月发布的《独董新规执行简报》显示，全年沪深两市上市公司共85名独立董事 因履职失责被罚或被采取监管措施，涉及案例58例。 三超新材的行为不是个例。12月中旬，善水科技宣布，拟从 ...

| 代码 | 名称 | | 涨幅% ↓ | 总市值 | 年初至今涨幅% | | --- | --- | --- | --- | --- | --- | | 300056 | 中创环保 | | 20.05 | 39.71亿 | -22.44 | | 300640 | 德艺文创 | | 12.42 | 28.14亿 | 60.87 | | 300096 | ST易联众 | 1 | 12.10 | 34.66 乙 | 154.26 | | 605299 | 舒华体育 | 1 | 10.04 | 64.17亿 | 103.49 | | 002682 | 龙洲股份 | 4-> | 10.03 | 53.65亿 | 125.53 | | 003016 | 欣贺股份 | | 10.03 | 48.91亿 | 34.45 | | 002229 | 鸿博股份 | | 10.01 | 91.10亿 | 53.13 | | 000905 | 厦门港务 | 1 | 10.00 | 108亿 | 105.07 | | 600693 | 东百集团 | 1 | 9.99 | 107亿 | 78.52 | | 603696 | 安记食品 | ...

Core Viewpoint - The A-share market in Fujian has seen significant gains, particularly in companies such as Fujian Expressway, Anji Food, and others, following the announcement of new policies aimed at enhancing cross-strait integration and supporting Taiwanese enterprises [1] Group 1: Market Performance - Fujian's A-share market experienced an afternoon surge, with several stocks hitting the daily limit, including Fujian Expressway and Anji Food [1] - Notable stocks that reached the 20% limit include Jiarong Technology and Zhaobiao Shares, while others like Haixin Food and Sun Cable hit the 10% limit [1] Group 2: Policy Measures - The Fujian Provincial Government announced the fifth batch of policy measures to support Taiwanese enterprises, consisting of 12 specific initiatives [1] - Key areas of support include: - Enhancing land and sea guarantees for Taiwanese enterprises and encouraging project construction in the Nanjing Precision Machinery Industrial Park [1] - Implementing tax service optimizations for Taiwanese businesses, including a smart tax platform and dedicated tax consultation lines [1] - Promoting trade and cultural exchanges, such as supporting Taiwanese individuals in opening restaurants and participating in local tourism initiatives [1]

Core Points - The company has approved the use of part of its temporarily idle raised funds for cash management, allowing for an investment of up to RMB 220 million within a 12-month period [1][6] - The company has successfully redeemed a RMB 200 million large-denomination certificate of deposit from a bank, with the principal and interest returned to the special account for raised funds [2][3] - The cash management aims to improve the efficiency of fund usage and increase returns for the company and its shareholders while ensuring the safety of the raised funds [2][7] Cash Management Details - The cash management amount is RMB 200 million, sourced from temporarily idle raised funds [3][2] - The investment product chosen is a large-denomination certificate of deposit, which meets the criteria for high safety and liquidity [5][3] - The company has established a special account for managing the raised funds, ensuring compliance with regulatory requirements [4][6] Approval Process - The board of directors and the supervisory board have approved the cash management proposal during meetings held on June 27, 2025 [1][6] - The approval process did not require a shareholders' meeting, as it falls within the board's authority [6][1] Impact on Operations - The cash management will not affect the normal operation of the company's main business or the funding of investment projects [7][6] - The strategy is expected to enhance the efficiency of fund usage and provide additional returns to shareholders [7][6] Recent Cash Management Activities - As of the announcement date, the company has a remaining balance of RMB 200 million in temporarily idle raised funds for cash management, with no overdue amounts [9][8]

Core Viewpoint - Xianheng International (605056) has announced a restricted stock incentive plan for 2025, aimed at motivating key personnel and aligning their interests with company performance [1] Group 1: Stock Performance - As of September 18, 2025, Xianheng International closed at 13.79 yuan, down 2.06% from the previous trading day, with a total market capitalization of 5.659 billion yuan [1] - The stock opened at 14.08 yuan, reached a high of 14.17 yuan, and a low of 13.59 yuan, with a trading volume of 53.8639 million yuan and a turnover rate of 0.95% [1] Group 2: Incentive Plan Details - The company plans to grant 6 million restricted stocks to 174 incentive targets, representing 1.46% of the total share capital, with a grant price of 7.29 yuan per share [1] - The incentive targets include senior management, core management personnel, and other individuals deemed necessary for motivation, excluding independent directors and supervisors [1] - The plan has a maximum validity period of 48 months, with lock-up periods of 12, 24, and 36 months, and the release ratio tied to performance metrics [1] Group 3: Performance Assessment - The performance assessment will be based on revenue and net profit targets for 2025-2027, with the release ratio linked to the achievement of these targets [1] - Individual performance evaluations will be categorized as excellent, qualified, or unqualified, corresponding to release ratios of 100%, 80%, and 0% respectively [1] - The implementation of this plan is subject to approval at the shareholders' meeting [1]

Core Viewpoint - Goldman Sachs Asian Strategy has reduced its stake in Xianheng International by 2.4881 million shares, representing 0.61% of the total share capital, bringing its holding to 5.00% due to its own funding needs [1] Summary by Relevant Categories - **Shareholding Changes** - The reduction in shareholding by Goldman Sachs Asian Strategy is significant, as it decreases their ownership to 5.00% [1] - The total number of shares sold in this transaction is 2.4881 million [1] - **Future Plans** - Goldman Sachs Asian Strategy has not completed its reduction plan and may consider further buying or selling within the next 12 months [1]

Core Viewpoint - *ST Huicheng (002168) reported a significant increase in revenue and a reduction in net loss for the first half of 2025, indicating potential recovery despite ongoing challenges [1]. Financial Performance Summary - Total revenue for the first half of 2025 reached 180 million yuan, a year-on-year increase of 61.54% compared to 111 million yuan in 2024 [1]. - The net profit attributable to shareholders was -31.67 million yuan, improving by 54.36% from -69.39 million yuan in the previous year [1]. - The gross profit margin improved to 51.22%, a substantial increase of 267.85% from 13.93% in 2024 [1]. - The net profit margin also improved to -14.06%, up 77.82% from -63.38% in the previous year [1]. - Operating cash flow per share increased to 0.07 yuan, a significant rise of 201.36% from -0.06 yuan [1]. Changes in Financial Items - Cash and cash equivalents increased by 328.26% to 65.89 million yuan due to increased sales collections [3]. - Accounts receivable rose by 71.18% to 246 million yuan, attributed to the consolidation of Reen Pharmaceutical [3]. - Long-term borrowings increased by 56.9% due to new long-term loans taken during the reporting period [4]. - Contract liabilities surged by 405.52% as a result of receiving project prepayments [4]. Cost and Expense Analysis - Sales expenses increased by 436.73% due to the addition of the pharmaceutical segment [4]. - Management expenses decreased by 48.2% as the company implemented cost-cutting measures [4]. - Research and development expenses rose by 108.33%, reflecting investment in the new pharmaceutical business [4]. Cash Flow and Debt Situation - The net cash flow from operating activities increased by 201.36%, driven by improved sales collections [4]. - The net increase in cash and cash equivalents was up by 151.56%, also due to increased sales collections [4]. - The company’s debt situation shows a significant reliance on interest-bearing liabilities, with a debt-to-asset ratio of 40.18% [5].

Core Viewpoint - Numerous listed companies, including Guoli Co. and New Classic, have recently announced the cancellation of their supervisory boards, reflecting a significant shift in corporate governance practices in response to new legal frameworks [1] Group 1: Corporate Governance Changes - Over 1,000 listed companies have announced the cancellation of their supervisory boards since March 2025, with more than 600 companies explicitly modifying their articles of association to reflect this change [1] - The adjustment is aimed at optimizing corporate governance structures and reducing management costs [1] - The new Company Law allows companies to establish an audit committee composed of directors, which can assume the supervisory functions previously held by the supervisory board [1] Group 2: Regulatory Framework - In March of this year, the China Securities Regulatory Commission revised and abolished certain regulations and normative documents related to the new Company Law [1] - Listed companies are required to clearly establish an audit committee in their articles of association by January 1, 2026, and grant it the supervisory powers previously held by the supervisory board [1]